StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3019% above fair value
$90.73−1.34 (-1.46%)

Close on Nov 20, 2026Market cap $5.00BP/E 26.8Yield –

LivaNova operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

LivaNova's operating income for the twelve months ending Jun 30, 2026 was $187.55M, up 6.9% year over year. For fiscal 2025 it was $199.39M, up 54.5% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $199.39M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$199.39M+54.5%
FY2024Dec 31, 2024$129.05M–
FY2023Dec 31, 2023-$68.50M–
FY2022Dec 31, 2022-$76.75M–
FY2021Dec 31, 2021-$784.00K–
FY2020Dec 31, 2020-$273.90M–
FY2019Dec 31, 2019-$171.55M–
FY2018Dec 31, 2018-$248.07M-357.1%
FY2017Dec 31, 2017$96.49M+8.8%
FY2015Apr 24, 2015$88.65M+10.8%
FY2014Apr 25, 2014$80.01M+2.1%
FY2013Apr 26, 2013$78.35M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$49.48M-8.7%
Q1 FY2026CQ1 2026Mar 31, 2026$41.47M-14.7%
Q4 FY2025CQ4 2025Dec 31, 2025$42.58M+15.0%
Q3 FY2025CQ3 2025Sep 30, 2025$54.01M+51.6%
Q2 FY2025CQ2 2025Jun 30, 2025$54.18M+34.9%
Q1 FY2025CQ1 2025Mar 31, 2025$48.62M+199.3%
Q4 FY2024CQ4 2024Dec 31, 2024$37.02M–
Q3 FY2024CQ3 2024Sep 30, 2024$35.62M+699.0%
Q2 FY2024CQ2 2024Jun 30, 2024$40.17M+131.2%
Q1 FY2024CQ1 2024Mar 31, 2024$16.25M–
Q4 FY2023CQ4 2023Dec 31, 2023-$87.99M-730.3%
Q3 FY2023CQ3 2023Sep 30, 2023$4.46M–
Q2 FY2023CQ2 2023Jun 30, 2023$17.38M-45.3%
Q1 FY2023CQ1 2023Mar 31, 2023-$2.34M-124.6%
Q4 FY2022CQ4 2022Dec 31, 2022$13.96M-43.6%
Q3 FY2022CQ3 2022Sep 30, 2022-$131.97M-903.6%
Q2 FY2022CQ2 2022Jun 30, 2022$31.76M–
Q1 FY2022CQ1 2022Mar 31, 2022$9.51M–
Q4 FY2021CQ4 2021Dec 31, 2021$24.75M–
Q3 FY2021CQ3 2021Sep 30, 2021$16.42M–
Q2 FY2021CQ2 2021Jun 30, 2021-$36.26M–
Q1 FY2021CQ1 2021Mar 31, 2021-$5.70M–
Q4 FY2020CQ4 2020Dec 31, 2020-$249.02M–
Q3 FY2020CQ3 2020Sep 30, 2020-$7.55M-129.3%
Q2 FY2020CQ2 2020Jun 30, 2020-$16.74M–
Q1 FY2020CQ1 2020Mar 31, 2020-$581.00K–
Q4 FY2019CQ4 2019Dec 31, 2019-$143.98M–
Q3 FY2019CQ3 2019Sep 30, 2019$25.76M–
Q2 FY2019CQ2 2019Jun 30, 2019-$29.88M-238.3%
Q1 FY2019CQ1 2019Mar 31, 2019-$20.78M-265.8%
Q4 FY2018CQ4 2018Dec 31, 2018-$276.45M-1559.4%
Q3 FY2018CQ3 2018Sep 30, 2018-$5.76M-119.2%
Q2 FY2018CQ2 2018Jun 30, 2018$21.61M-22.2%
Q1 FY2018CQ1 2018Mar 31, 2018$12.53M-36.5%
Q4 FY2017CQ4 2017Dec 31, 2017$18.94M+13.3%
Q3 FY2017CQ3 2017Sep 30, 2017$30.02M–
Q2 FY2017CQ2 2017Jun 30, 2017$27.78M–
Q1 FY2017CQ1 2017Mar 31, 2017$19.75M–
Q4 FY2015CQ1 2015Apr 24, 2015$16.72M–

More LivaNova figures

See a number that looks wrong?